Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

IEX · Q3 2025 Earnings

IDEX Corporation

Reported October 29, 2025

30-second summary

Q3 organic sales grew 5% (vs. guide of 2–3%) and adjusted EPS of $2.03 beat the $1.90–$1.95 guide, with HST reported revenue up 22% (organic +10%) as Mott rolls through its final pre-anniversary quarter. Management used the beat to narrow — not raise — the full-year adjusted EPS range to $7.86–$7.91 (within the prior $7.85–$7.95 range), trimming the high end by $0.04 while lifting the low end by $0.01, and explicitly flagged macro uncertainty extending into 2026. The Q3 print is genuinely better; the forward posture is more defensive than the headline suggests.

Headline numbers

EPS

Q3 FY2025

$2.03

Revenue

Q3 FY2025

$0.88B

+10.0% YoY

Gross margin

Q3 FY2025

44.5%

Free cash flow

Q3 FY2025

$0.19B

Operating margin

Q3 FY2025

21.1%

Key financials

Q3 FY2025

Metric	Q3 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$0.88B	+10.0%	$0.86B	+1.6%
EPS	$2.03	—	$2.07	-1.9%
Gross margin	44.5%	—	45.3%	-80bps
Operating margin	21.1%	—	21.7%	-60bps
Free cash flow	$0.19B	—	$0.15B	+28.4%

Guidance

Q3 beat on EPS and organic growth; full-year adjusted EPS guidance slightly lowered, GAAP eps narrowed range, organic growth and FCF conversion reaffirmed, cost-savings disclosed.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

Metric	Period	Prior guide	Actual	Δ	Result
GAAP diluted EPS	Q3 FY2025	$1.54 - $1.61	$1.70	+$0.09 above guide high	Beat
Adjusted diluted EPS	Q3 FY2025	$1.90 - $1.95	$2.03	+$0.08 above guide high	Beat
Organic sales growth	Q3 FY2025	2% to 3%	5%	+2pts above guide high	Beat

New guidance

Metric	Period	Guide	YoY
Platform optimization and cost containment savings	FY2025	$60+ million	—
Free cash flow conversion	FY2025	at least 100%	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
GAAP diluted EPS	FY2025	$6.30 - $6.44	$6.35 - $6.40	midpoint +$0.005, range narrowed; net slight raise	Raised
Adjusted diluted EPS	FY2025	$7.85 - $7.95	$7.86 - $7.91	midpoint -$0.035 (from $7.90 to $7.885)	Lowered

Reaffirmed unchanged this quarter: Organic sales growth (approximately 1%)

Segment KPIs

Q3 FY2025

Segment	Q3 FY2025	YoY
Health & Science Technologies	$0.381B	+22.0%
Fluid & Metering Technologies	$0.317B	+5.0%
Fire & Safety/Diversified Products	$0.182B	-3.0%
HST Adjusted EBITDA margin	27.7%	—
FMT Adjusted EBITDA margin	33.7%	—
FSDP Adjusted EBITDA margin	27.1%	—

Other KPIs

Q3 FY2025

Segment	Q3 FY2025
Organic sales growth	5%
Organic orders growth	7%
Adjusted EBITDA margin	27.3%
Free cash flow conversion	123%
Share repurchases	$75.0 million

Management tone

Q3 2024 anchor unavailable → Q1 2025 platform-build execution → Q2 2025 policy-whiplash reset → Q3 2025 operational discipline and capital return.

The M&A doctrine has formally flipped. Q2's tone was "opportunistic tuck-ins after the platform build." This quarter management hardened that into policy: "We do not expect to pursue large acquisition opportunities in the near term after investing in the establishment of our growth platforms over the last couple of years. Instead, we will be focused on bolt-ons and portfolio optimization in the coming quarters." Paired with $75M of Q3 buybacks and explicit disclosure of "≥100% FCF conversion" as a guided metric, this is a capital-allocation regime change from growth-via-deal to return-of-cash.

Macro horizon pushed out, not pulled in. Q2 framed the freeze as a policy event with a July inflection. This quarter, the language extends well past the next print: "we see a dynamic macro environment with an uncertainty overhang that we expect will continue into 2026. It's not clear how and when broad external catalysts will line up to support more predictable and positive conditions." That single sentence — combined with the adjusted EPS high-end trim — explains why a beating quarter produced a tighter, slightly lower top-end guide.

Two-speed economy is now the operating framework. Where Q2 described broad weakness with platform exceptions, Q3 codifies the bifurcation: "There's those areas that we focus that are really contributing to our growth, and those are dynamic and aggressive and exciting, data centers…and then you have kind of the broad economy next to it…much more fragmented." This is management telegraphing that the ISMX-correlated legacy business is not the swing factor anymore — HST and data center exposure are.

80-20 emerges as the central operating verb. Mott and Muon were positioned in Q2 as growth assets needing time to inflect. This quarter the language is integration and extraction: "we are intensively deploying 80-20 in these areas to enhance efficiencies and productivity and unlock integrated growth potential." Read alongside the $60M+ cost savings disclosure, this signals the playbook for 2026 is margin expansion from acquired assets, not revenue acceleration.

Recurring themes management leaned on this quarter:

Phase three evolution through integration and 80-20 optimization of acquired platformsBifurcated demand environment: secular growth platforms vs. flat industrial exposureCapital allocation shift from transformational M&A to bolt-ons and shareholder returnsOperational leverage and margin expansion from cost containment and platform optimizationTariff-driven pricing at elevated levels with emerging customer fatigueShort-cycle business model with limited forward visibility

Risks management surfaced:

Macro uncertainty and policy direction creating decision elongation on larger ordersPricing fatigue limiting ability to sustain 3.5% price capture levelsFire and safety segment pressured by funding disruptions and sluggish equipment replenishmentSemiconductor lithography remaining below prior year as headwind to HST growthPotential policy changes impacting trade, tariffs, and geopolitical stability

Answers to last quarter's watch list

Does the July order recovery sustain into August/September? Yes — Q3 organic orders grew 7% and organic sales 5%, both well above the 2–3% guide. The recovery held through the quarter.

Resolved positively

Mott revenue and margin trajectory in Q3. HST reported revenue grew 22% (organic +10%, with ~11pts from Mott in the inorganic bucket through September 2025) and segment EBITDA margin lifted 120bps YoY to 27.7%, consistent with management's accretion-exiting-the-year framing. The company did not disclose a Mott-specific dollar contribution, but no second recalibration occurred.

Resolved positively

Muon/semi-lithography commentary. Management noted semiconductor lithography remains below prior year and continues as a headwind to HST — consistent with the Q2 "flatter for a while" framing, with no inflection timeline offered. Muon-specific profitability moved above HST segment average on 80-20 actions.

Continue monitoring

HST segment EBITDA margin progression. 27.7% in Q3, +120bps YoY, supported by volume leverage, platform optimization savings, and favorable price/cost.

Resolved positively

Capital deployment cadence. $75M of buybacks executed in Q3 ($175M YTD), share repurchase authorization increased to $1B, and management explicitly ruled out large M&A in the near term in favor of bolt-ons and shareholder returns. The pivot is confirmed.

Resolved positively

What to watch into next quarter

Q4 implied adjusted EPS math. The new $7.86–$7.91 FY range with $2.03 Q3 actual implies a Q4 adjusted EPS in roughly the $1.84–$1.89 zone — watch whether this prints in-line or requires another trim. The high-end cut signals limited cushion.

HST organic growth as the Mott anniversary hits in Q4 2025. Mott closed in September 2024, so ~11pts of inorganic lift roll off in Q4 — the Q4-Q1 read will separate acquired-revenue lift from underlying platform momentum on a clean organic basis.

Price contribution durability. Price was called out as a primary driver across all three segments this quarter. Watch for the first quarter in which price contribution to organic growth steps down meaningfully — that's when tariff-offset pricing is running out of runway.

Whether the $60M cost savings flow through to FY2026 margin guidance or get reinvested. Management said "we see a path for continued margin expansion going forward" — the initial FY26 framing on the Q4 call will reveal whether savings are dropping to the bottom line or funding offsets.

FSDP stabilization. Organic −5% with margin compressing 200bps YoY; fire & safety funding disruption (notably ex-U.S.) was flagged as a structural risk. Watch for a second consecutive decline that would signal something worse than transitory.

Buyback cadence vs. leverage. $75M in Q3 is a real step-up, with gross leverage at ~2.1x and management targeting a return to under 2x in the next several quarters. Watch whether Q4 sustains or accelerates the pace as the bolt-on/return-cash regime gets tested.

Sources

IDEX Q3 FY2025 press release / 8-K exhibit 99.1: https://www.sec.gov/Archives/edgar/data/832101/000162828025046909/iex-20250930xex991.htm

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.